127 related articles for article (PubMed ID: 12270763)
1. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease.
Suzuki T; Kohno H; Hasegawa A; Toshima S; Amaki T; Kurabayashi M; Nagai R; Suzuki T; Amaki T; Nagai R; Hasegawa A; Toshima S; Kurabayashi MH; Shimada K; Nakamura H; Teramoto T; Yamaguchi H; Nishiyama S; Takahashi H; Michishita I; Sugano Z; Konoshi K;
Clin Biochem; 2002 Jul; 35(5):347-53. PubMed ID: 12270763
[TBL] [Abstract][Full Text] [Related]
2. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease.
Holvoet P; Mertens A; Verhamme P; Bogaerts K; Beyens G; Verhaeghe R; Collen D; Muls E; Van de Werf F
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):844-8. PubMed ID: 11348884
[TBL] [Abstract][Full Text] [Related]
3. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
[TBL] [Abstract][Full Text] [Related]
4. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
5. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease.
Toshima S; Hasegawa A; Kurabayashi M; Itabe H; Takano T; Sugano J; Shimamura K; Kimura J; Michishita I; Suzuki T; Nagai R
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2243-7. PubMed ID: 11031210
[TBL] [Abstract][Full Text] [Related]
6. Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease.
Bliden KP; Chaudhary R; Lopez LR; Damrongwatanasuk R; Guyer K; Gesheff MG; Franzese CJ; Kaza H; Tantry US; Gurbel PA
Am J Cardiol; 2016 Sep; 118(5):673-8. PubMed ID: 27401271
[TBL] [Abstract][Full Text] [Related]
7. Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease.
Sheikh MSA
Balkan Med J; 2021 Jan; 38(1):13-22. PubMed ID: 33593717
[TBL] [Abstract][Full Text] [Related]
8. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
[TBL] [Abstract][Full Text] [Related]
9. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
10. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
Li GX; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
[TBL] [Abstract][Full Text] [Related]
12. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.
Fraley AE; Tsimikas S
Curr Opin Lipidol; 2006 Oct; 17(5):502-9. PubMed ID: 16960498
[TBL] [Abstract][Full Text] [Related]
13. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL).
Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M
Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma oxidized low-density lipoprotein and the coronary vasomotor response to acetylcholine in patients with coronary artery disease.
Nakaishi T; Tamura A; Watanabe T; Mikuriya Y; Nasu M
Jpn Circ J; 2000 Nov; 64(11):856-60. PubMed ID: 11110431
[TBL] [Abstract][Full Text] [Related]
15. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
16. [Oxidized LDL in patients with coronary heart disease and normal subjects].
Hasegawa A; Toshima S; Nakano A; Nagai R
Nihon Rinsho; 1999 Dec; 57(12):2754-8. PubMed ID: 10638208
[TBL] [Abstract][Full Text] [Related]
17. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk.
Maggi E; Finardi G; Poli M; Bollati P; Filipponi M; Stefano PL; Paolini G; Grossi A; Clot P; Albano E
Coron Artery Dis; 1993 Dec; 4(12):1119-22. PubMed ID: 8162245
[TBL] [Abstract][Full Text] [Related]
18. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy.
Jankowski J; Nofer JR; Tepel M; Griewel B; Schlüter H; Assmann G; Zidek W
Clin Sci (Lond); 1998 Oct; 95(4):489-95. PubMed ID: 9748425
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
